Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001415889-24-006170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-01 | 2024-01-15 | KNSA | Megna Michael R | CAO | A - Grant | $12.35 | +583 | 17.6K | +3% | +$7,200 |
| DM | 2024-03-01 | 2024-02-28+ | KNSA | Megna Michael R | CAO | M - OptEx | $10.20 | +14.8K | 27.2K | +119% | +$150.8K |
| DM | 2024-03-01 | 2024-02-28+ | KNSA | Megna Michael R | CAO | S - Sale+OE | $21.57 | -14.8K | 17.6K | -46% | -$318.9K |
| DM | 2024-03-01 | 2024-02-28+ | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -14.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2024-01-15 | A | A | 583 | $12.35 | 17,588 | D | — | — | |
| 2 | Common | Class A Common Share | 2024-02-28 | M | A | 5,126 | $8.83 | 22,714 | D | — | — | |
| 3 | Common | Class A Common Share | 2024-03-01 | S | D | 9,659 | $21.45 | 17,588 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.45 to $21.49. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Common Share | 2024-03-01 | M | A | 5,645 | $8.83 | 23,233 | D | — | — | |
| 5 | Common | Class A Common Share | 2024-03-01 | M | A | 4,014 | $13.88 | 27,247 | D | — | — | |
| 6 | Common | Class A Common Share | 2024-02-28 | S | D | 5,126 | $21.79 | 17,588 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.56 to $21.90. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 7 | Derivative | Share Option | 2024-02-28 | M | D | 5,126 | $0.00 | 5,874 | D | $8.83 · — to 2029-09-16 | 5,126 Class A Common Share | (F5) This option is fully vested and exercisable. |
| 8 | Derivative | Share Option | 2024-03-01 | M | D | 5,645 | $0.00 | 229 | D | $8.83 · — to 2029-09-16 | 5,645 Class A Common Share | (F5) This option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2024-03-01 | M | D | 4,014 | $0.00 | 0 | D | $13.88 · — to 2028-08-05 | 4,014 Class A Common Share | (F5) This option is fully vested and exercisable. |